|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Chlamydia/N. gonorrhoeae, T. vaginalis, Qualitative, TMA and HSV-1/2 DNA, Real-Time PCR, Pap Vial
Test Code91437
CPT Codes
87491, 87591, 87529 (x2), 87661
Includes
Chlamydia/Neisseria gonorrhoeae RNA, TMA, Urogenital
Herpes Simplex Virus, Type 1 and 2 DNA, Real-Time PCR, Pap Vial
Trichomonas vaginalis RNA, Qualitative, TMA, PAP Vial
Herpes Simplex Virus, Type 1 and 2 DNA, Real-Time PCR, Pap Vial
Trichomonas vaginalis RNA, Qualitative, TMA, PAP Vial
Preferred Specimen
1 mL liquid cytology (PreservCyt®) preservative (ThinPrep®) collected in an APTIMA® transfer tube (green label), or
0.5 mL SurePath™ preservative fluid collected in an APTIMA® transfer tube (green label)
Minimum Volume
1 mL PreservCyt (ThinPrep) • 0.5 mL SurePath fluid in APTIMA
Other Acceptable Specimens
2 mL (2 mL minimum) PreservCyt® ThinPrep® vial, or
1 mL (1 mL minimum) SurePath™ vial
1 mL (1 mL minimum) SurePath™ vial
Instructions
PreservCyt or SurePath material already processed for cytology or Pap are not acceptable.
Labs performing cytology: Aliquot PreservCyt solution before performance of liquid-based cytology testing.
PreservCyt: Transfer 1 mL PreservCyt solution into APTIMA transfer tube (green label).
SurePath: SurePath fluid must be transferred to APTIMA tube within 4 days of collection. Transfer 0.5 mL SurePath solution into APTIMA transfer tube(green label).
Transport Temperature
Room temperature
Specimen Stability
PreservCyt ThinPrep and SurePath in APTIMA transport tube
Room temperature: 14 days
Refrigerated: 14 days
Frozen: 14 days
PreservCyt ThinPrep Vial and SurePath fluid vial
Room temperature: 4 days
Refrigerated: 4 days
Frozen: Unacceptable
Room temperature: 14 days
Refrigerated: 14 days
Frozen: 14 days
PreservCyt ThinPrep Vial and SurePath fluid vial
Room temperature: 4 days
Refrigerated: 4 days
Frozen: Unacceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
PreservCyt® ThinPrep® or SurePath™ material previously processed for cytology • PreservCyt® ThinPrep or SurePath™ with excess mucus • Specimens submitted in Aptima® tubes with pierced foil lids
Methodology
Real-Time Polymerase Chain Reaction • Transcription-Mediated Amplification (TMA)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Daily; Report available: Next day
Reference Range
C. trachomatis RNA, TMA | Not detected |
N. gonorrhoeae RNA, TMA | Not detected |
HSV-1 DNA | Not detected |
HSV-2 DNA | Not detected |
T. vaginalis RNA, QL TMA | Not detected |
Clinical Significance
Diagnosis of the four most common sexually transmitted infections.
Performing Laboratory
Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly, VA 20153